Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults.
about
Pneumococcal vaccine and patients with pulmonary diseasesComparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysisComparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly.Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): a guide to its use in older adults.Is it worth investigating splenic function in patients with celiac disease?Pneumococcal vaccine and opsonic pneumococcal antibody.13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults.Streptococcus pneumoniae serotype 19A: Worldwide epidemiology.Pneumococcal conjugate vaccine use in adults.Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2017-18 Influenza Season.Pneumococcal vaccination and chronic respiratory diseases.Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age.Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1.Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany.Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in AustraliaPrevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season
P2860
Q26825944-03448346-A0C5-494A-B379-78EB6FBEE6CFQ37561339-D33981E2-A4B0-4BA4-B21A-FCD1C4B71486Q37625249-71AF3985-A05C-40CA-92A9-986E7E9F8116Q38049557-90BB8462-33D9-4528-8D79-918FD2A6391EQ38101325-F613954A-6959-4260-9211-5B9F84A9E23DQ38105255-21188539-E7E1-4CDC-9FC6-641C087DA6E7Q38560859-456AF55F-F260-45B3-AE0C-D96D0D2F8D76Q38637072-0995C4B9-06E8-4A7B-9704-9331C17FF283Q38664425-1EF8DE70-4680-4FBF-A935-0D0600D1BC16Q40070473-613E479A-87DA-4AD9-82B9-542B8310EEFDQ43167908-4E2E95E4-44D2-401C-A216-55A6ECC37CBDQ47162758-626EE228-A9C6-46FA-8939-77C7C9D0CF11Q48222344-25D2B329-A958-4244-86ED-E5ACCFDE112AQ52805649-2D306EA9-925F-4C5B-9CBE-C6697ABA993BQ52844673-36148E60-748D-4439-8F1F-469E50999B01Q57812045-67C4F9F6-D12A-4E99-9350-5F7022EE21EEQ58709341-A465E901-3796-4399-8B8C-4F37E4CABF66
P2860
Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Randomized, controlled trial o ...... nza vaccine in healthy adults.
@ast
Randomized, controlled trial o ...... nza vaccine in healthy adults.
@en
type
label
Randomized, controlled trial o ...... nza vaccine in healthy adults.
@ast
Randomized, controlled trial o ...... nza vaccine in healthy adults.
@en
prefLabel
Randomized, controlled trial o ...... nza vaccine in healthy adults.
@ast
Randomized, controlled trial o ...... nza vaccine in healthy adults.
@en
P2093
P2860
P356
P1476
Randomized, controlled trial o ...... nza vaccine in healthy adults.
@en
P2093
Alejandra Gurtman
Beate Schmöle-Thoma
Daniel A Scott
Deepthi Jayawardene
Emilio A Emini
John Rubino
Martin van Cleeff
Peter C Giardina
Robert W Frenck
William C Gruber
P2860
P304
P356
10.1128/CVI.00176-12
P577
2012-06-27T00:00:00Z